Source

European Journal of Preventive Cardiology

3 developments in the corpus

Latest

Everything in the corpus, newest first.

SEP 16, 2026 · JOURNAL ARTICLE

Metabolic obesity phenotypes and degenerative valvular heart disease: A cohort study

European Journal of Preventive Cardiology

Abstract Aims We evaluated the association between metabolic obesity phenotypes and degenerative valvular heart disease (VHD) risk, and elucidate underlying molecular pathways via

AUG 18, 2026 · JOURNAL ARTICLE

Glucagon-Like Peptide-1–Based Therapies in Cardiovascular Disease: Evidence, Mechanisms, and Emerging Clinical Applications

European Journal of Preventive Cardiology

A narrative review synthesizing evidence on GLP-1 and GIP/GLP-1 therapies across cardiovascular disease, diabetes, obesity, and heart failure—providing expert synthesis rather than new primary data.

Expert GuidanceNicola Ammirabile Davide Capodanno Maria Sara Mauro

Study details

DesignNarrative review

JUN 30, 2026 · JOURNAL ARTICLE

Technology-assisted physical activity among hospitalized medical patients: a cluster randomized trial

European Journal of Preventive Cardiology

Cluster randomized trial with statistically significant primary endpoint (23.6 min/day increase out of bed, 95% CI 13.7–33.5) and secondary endpoint (440 steps/day), demonstrating efficacy of technology-assisted monitoring in a relevant hospitalized population.

Strong EvidenceCharlotte Suetta Marius Henriksen Lars Pedersen

Reported

Primary endpoint—mean time out of…143.5 (SD 96.6) min/day

Primary endpoint—mean time out of…120.8 (SD 75.2) min/day

Absolute difference in time out o…23.6 min/day